Evan Popoff

820 total citations
43 papers, 567 citations indexed

About

Evan Popoff is a scholar working on Psychiatry and Mental health, Molecular Biology and Neurology. According to data from OpenAlex, Evan Popoff has authored 43 papers receiving a total of 567 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Psychiatry and Mental health, 10 papers in Molecular Biology and 6 papers in Neurology. Recurrent topics in Evan Popoff's work include Migraine and Headache Studies (15 papers), Complement system in diseases (4 papers) and Trigeminal Neuralgia and Treatments (4 papers). Evan Popoff is often cited by papers focused on Migraine and Headache Studies (15 papers), Complement system in diseases (4 papers) and Trigeminal Neuralgia and Treatments (4 papers). Evan Popoff collaborates with scholars based in United States, Canada and United Kingdom. Evan Popoff's co-authors include Steve Kanters, Edward J. Mills, Nathan Ford, M. Eugenia Socías, Marco Vitória, Meg Doherty, Sabin Nsanzimana, Karissa Johnston, Linda Harris and Jamie I. Forrest and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Neurology.

In The Last Decade

Evan Popoff

38 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Evan Popoff United States	13	239	113	111	104	66	43	567
Vanesa Balboa‐Barreiro Spain	14	104 0.4×	52 0.5×	27 0.2×	55 0.5×	69 1.0×	65	619
Rainel Sánchez-de la Rosa Spain	12	111 0.5×	89 0.8×	37 0.3×	22 0.2×	106 1.6×	37	441
Amanda M. Farr United States	12	116 0.5×	35 0.3×	24 0.2×	87 0.8×	30 0.5×	36	441
Pamela Clax United States	7	160 0.7×	30 0.3×	14 0.1×	74 0.7×	17 0.3×	11	484
Ying Shao China	12	107 0.4×	42 0.4×	13 0.1×	51 0.5×	14 0.2×	53	409
Iñaki Pérez Spain	15	218 0.9×	101 0.9×	9 0.1×	208 2.0×	28 0.4×	29	670
Jessie Githanga Kenya	13	100 0.4×	21 0.2×	39 0.4×	50 0.5×	100 1.5×	27	890
Arantza Sanvisens Spain	17	129 0.5×	40 0.4×	7 0.1×	455 4.4×	198 3.0×	61	745
Jessica Opie South Africa	9	87 0.4×	17 0.2×	72 0.6×	33 0.3×	57 0.9×	31	312
Aasim Sheikh United States	15	155 0.6×	18 0.2×	22 0.2×	724 7.0×	40 0.6×	27	957

Countries citing papers authored by Evan Popoff

Since Specialization

Citations

This map shows the geographic impact of Evan Popoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evan Popoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evan Popoff more than expected).

Fields of papers citing papers by Evan Popoff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evan Popoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evan Popoff. The network helps show where Evan Popoff may publish in the future.

Co-authorship network of co-authors of Evan Popoff

This figure shows the co-authorship network connecting the top 25 collaborators of Evan Popoff. A scholar is included among the top collaborators of Evan Popoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evan Popoff. Evan Popoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Potashman, Michele, Evan Popoff, Lauren Powell, et al.. (2025). Measurement Properties of the Friedreich Ataxia Rating Scale in Patients with Spinocerebellar Ataxia. Neurology and Therapy. 14(2). 527–545.

Johnston, Karissa, et al.. (2024). Cost-effectiveness of rimegepant oral lyophilisate compared to best supportive care for the acute treatment of migraine in the UK. Journal of Medical Economics. 27(1). 627–643. 3 indexed citations

Szabo, Shelagh M., et al.. (2024). Observing the Clinical Course of Duchenne Muscular Dystrophy in Medicaid Real-World Healthcare Data. Advances in Therapy. 41(6). 2519–2530.

Potashman, Michele, Evan Popoff, Lauren Powell, et al.. (2024). Psychometric Validation of the Modified Functional Scale for the Assessment and Rating of Ataxia (f-SARA) in Patients With Spinocerebellar Ataxia. The Cerebellum. 23(5). 2095–2108. 5 indexed citations

O’Byrne, Kenneth J., Evan Popoff, Firas Badin, et al.. (2023). EP11.03-23 Efficacy of Nivolumab + Ipilimumab Vs other First-line Treatments for Metastatic NSCLC with PD-L1 <1%: a Network Meta-analysis. Journal of Thoracic Oncology. 18(11). S629–S630.

Schrezenmeier, Hubert, Austin Kulasekararaj, Lindsay Mitchell, et al.. (2023). Predictors for improvement in patient-reported outcomes: post hoc analysis of a phase 3 randomized, open-label study of eculizumab and ravulizumab in complement inhibitor-naive patients with paroxysmal nocturnal hemoglobinuria. Annals of Hematology. 103(1). 5–15. 6 indexed citations

Powell, Lauren, Gilbert L’Italien, Evan Popoff, et al.. (2022). Health State Utility Mapping of Rimegepant for the Preventive Treatment of Migraine: Double-Blind Treatment Phase and Open Label Extension (BHV3000-305). Advances in Therapy. 40(2). 585–600. 8 indexed citations

Johnston, Karissa, Linda Harris, Lauren Powell, et al.. (2022). Monthly migraine days, tablet utilization, and quality of life associated with Rimegepant – post hoc results from an open label safety study (BHV3000–201). The Journal of Headache and Pain. 23(1). 10–10. 24 indexed citations

Szabo, Shelagh M., et al.. (2022). Characterizing the Occurrence of Key Clinical Milestones in Duchenne Muscular Dystrophy in the United States Using Real-World Data. Journal of Neuromuscular Diseases. 9(6). 689–699. 7 indexed citations

10.

L’Italien, Gilbert, Evan Popoff, Linda Harris, et al.. (2021). Acute Treatment with Rimegepant 75 mg Confers Long Term Improvements in Median Time to 30% and 50% Reductions in Monthly Migraine Days – Post Hoc Results from an Open Label Safety Study (BHVN-3000-201) (4737). Neurology. 96(15_supplement). 1 indexed citations

11.

Johnston, Karissa, Gilbert L’Italien, Evan Popoff, et al.. (2021). Mapping Migraine-Specific Quality of Life to Health State Utilities in Patients Receiving Rimegepant. Advances in Therapy. 38(10). 5209–5220. 15 indexed citations

12.

Popoff, Evan, et al.. (2020). PRO36 A US COST-MINIMIZATION MODEL COMPARING LIFETIME PER-PATIENT COSTS FOR RAVULIZUMAB AND ECULIZUMAB FOR THE TREATMENT OF ATYPICAL HEMOLYTIC UREMIC SYNDROME. Value in Health. 23. S335–S335. 1 indexed citations

13.

Popoff, Evan, et al.. (2020). Aligning text mining and machine learning algorithms with best practices for study selection in systematic literature reviews. Systematic Reviews. 9(1). 293–293. 18 indexed citations

14.

Cope, Shannon, Evan Popoff, Rafaël Fonseca, et al.. (2020). Critical Appraisal of Published Indirect Comparisons and Network Meta-Analyses of Competing Interventions for Multiple Myeloma. Value in Health. 23(4). 441–450. 9 indexed citations

15.

Cope, Shannon, et al.. (2019). PCN29 COMPARATIVE EFFICACY OF NIVOLUMAB VERSUS RELEVANT TREATMENTS IN PRETREATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): A SYSTEMATIC LITERATURE REVIEW AND INDIRECT TREATMENT COMPARISON OF RANDOMIZED CONTROLLED TRIALS (RCTS). Value in Health. 22. S440–S440. 2 indexed citations

16.

Mills, Edward J., Achyuta Adhvaryu, Pamela Jakiela, et al.. (2018). Unconditional cash transfers for clinical and economic outcomes among HIV-affected Ugandan households. AIDS. 32(14). 2023–2031. 19 indexed citations

17.

Cope, Shannon, Evan Popoff, Rachel Goldgrub, et al.. (2018). PCN21 - COMPARATIVE EFFICACY OF NIVOLUMAB±IPILIMUMAB VERSUS STANDARD OF CARE (SOC) FOR THIRD-LINE (3L) PATIENTS WITH RECURRENT SMALL CELL LUNG CANCER (SCLC) USING POPULATION-ADJUSTED INDIRECT COMPARISON. Value in Health. 21. S18–S18. 2 indexed citations

18.

Mutasa‐Apollo, Tsitsi, Nathan Ford, Matthew O. Wiens, et al.. (2017). Effect of frequency of clinic visits and medication pick‐up on antiretroviral treatment outcomes: a systematic literature review and meta‐analysis. Journal of the International AIDS Society. 20(S4). 21647–21647. 56 indexed citations

19.

Kanters, Steve, M. Eugenia Socías, Nicholas I. Paton, et al.. (2017). Comparative efficacy and safety of second-line antiretroviral therapy for treatment of HIV/AIDS: a systematic review and network meta-analysis. The Lancet HIV. 4(10). e433–e441. 52 indexed citations

20.

Kanters, Steve, Marco Vitória, Meg Doherty, et al.. (2016). Comparative efficacy and safety of first-line antiretroviral therapy for the treatment of HIV infection: a systematic review and network meta-analysis. The Lancet HIV. 3(11). e510–e520. 142 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact